Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Retrospective cross-sectional study of cancer prevalence and inflammatory biomarkers in a single Italian cohort with no comparator group; descriptive and exploratory design that characterizes associations but cannot establish causation or clinical utility of the composite score.
Retrospective single-centre assessment of theoretical eligibility and drug-drug interactions; descriptive analysis without a comparator, control group, or clinical outcome measurement.
Rigorous nationwide retrospective cohort study with propensity score matching, large sample size, and consistent effect across multiple analytical approaches and subgroups, establishing a clinically significant increased risk of PJP with ICIs in lung cancer.
A narrative review synthesizing heterogeneous observational studies with acknowledged limited and incompletely understood evidence; raises questions about HIV–ovarian cancer association rather than establishing a definitive answer.
A single case report documenting an unusual clinical trajectory; provides descriptive evidence of disease evolution but lacks comparative data, control group, or generalizable findings.
A single case report with no comparator, describing anecdotal response to a novel drug combination in an unusual population; insufficient to change practice or confirm efficacy.
A single case report describing a rare presentation of CNS lymphoma with novel molecular findings; raises diagnostic and clinical awareness but provides no comparative data or outcome evidence.